EDN1 and pulmonary arterial hypertension: While insight into some molecular pathways in PAH such as endothelin-1 dependent, prostacyclin-mediated, role of vascular calcium channels and nitric oxide driven pathways, have aided in development of newer targeted therapies for PAH with improved quality of life, the overall mortality in PAH has not significantly changed, with only modest improvement in functional and hemodynamic parameters.